Recombinant Human LILRB2/CD85d/ILT4 Fc Biotin Protein, CF

Name: Recombinant Human LILRB2/CD85d/ILT4 Fc Biotin Protein, CF
Brand: R&D Systems
SKU: BT2078
Price: 497 USD

Catalog #: BT2078 Datasheet / COA / SDS

Fc Chimera Biotinylated

Discontinued Product

BT2078 has been discontinued.

View all LILRB2/CD85d/ILT4 products.

Biotinylated Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera Protein Binding Activity.

2 Images

All LILRB2/CD85d/ILT4 Proteins and Enzymes

Product Details

FAQs

Supplemental Products

Reviews

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human LILRB2/CD85d/ILT4 Fc Biotin Protein, CF Summary

Product Specifications

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

Activity

Measured by its binding ability in a functional ELISA. When Recombinant Human Angiopoietin-like Protein 2/ANGPTL2 C-Terminal Fragment (Catalog # 9795-AN) is immobilized at 1 µg/mL (100 µL/well), Biotinylated Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera (Catalog # BT2078) binds with an ED₅₀ of 10.0-80.0 ng/mL.

Source

Mouse myeloma cell line, NS0-derived human LILRB2/CD85d/ILT4 protein

Human LILRB2/CD85d/ILT4 (Gly24-His458) Accession # AAH36827.1	IEGRMD	Human IgG₁ (Pro100-Lys330)
N-terminus		C-terminus

Accession #

AAH36827.1

N-terminal Sequence
Analysis

Gly24

Structure / Form

Disulfide-linked homodimer

Biotinylated via Amines

Predicted Molecular Mass

73.9 kDa (monomer)

SDS-PAGE

82-100 kDa, under reducing conditions.

Product Datasheets

BT2078

Product Datasheet

COA

SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

BT2078

Formulation	Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution	Reconstitute at 250 μg/mL in PBS.
Shipping	The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Scientific Data

Binding Activity

View Larger

When Recombinant Human Angiopoietin-like Protein 2/ANGPTL2 C-Terminal Fragment (9795-AN) is immobilized at 1 µg/mL (100 µL/well), Biotinylated Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera Protein (Catalog # BT2078) binds with an ED₅₀of 10.0-80.0 ng/mL.

SDS-PAGE

View Larger

2 μg/lane of Biotinylated Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera Protein (Catalog # BT2078) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 82-100 kDa.

Reconstitution Calculator

Background: LILRB2/CD85d/ILT4

The immunoglobulin-like transcript (ILT) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIR) (1-3). ILT4, also known as LIR-2 and LILRB2, is a type I transmembrane protein expressed primarily on monocytes and dendritic cells (DC) (4). Human ILT4 is produced as a 598 amino acid (aa) precursor including a 21 aa signal sequence, a 440 aa extracellular domain (ECD), a 21 aa transmembrane segment, and a 116 aa cytoplasmic domain. The ECD contains four Ig-like domains, and the cytoplasmic domain contains three immunoreceptor tyrosine-based inhibitory motifs (ITIM) (5). The ECD of human ILT4 shares 76% aa identity with chimpanzee ILT4 and 74%, 81%, 33%, 52%, 77%, 61%, and 64 % aa identity with human ILT1, 2, 3, 5, 6, 7, and 8, respectively. ILT4 binds to classical MHC I proteins as well as the non-classical HLA-G1 and HLA-F molecules (5-9). It competes with CD8 alpha for MHC I binding but does not compete with KIR2DL1 (7). Ligation of ILT4 induces Tyr phosphorylation within its cytoplasmic ITIMs, a requirement for association with SHP-1 (4, 6). Activation of ILT4 inhibits signaling through Fc gamma RI (4) and Fc epsilon RI (6) and causes DC to become tolerogenic by down‑regulation of co‑stimulatory molecules (10, 11). ILT4 mediates tolerogenic DC‑induced CD4+ T cell energy in vitro and in vivo (10-12).

References

Suciu-Foca, N. et al. (2005) Int. Immunopharmacol. 5:7.
Hofmeister, V. and E.H. Weiss (2003) Semin. Canc. Biol. 13:317.
Hunt, J.S. et al. (2005) FASEB J. 19:681.
Finger, N.A. et al. (1998) Eur. J. Immunol. 28:3423.
Borges, L. et al. (1997) J. Immunol. 159:5192.
Colonna, M. et al. (1998) J. Immunol. 160:3096.
Shiroishi, M. et al. (2003) Proc. Natl. Acad. Sci. 100:8856.
Lepin, E.J.M. et al. (2000) Eur. J. Immunol. 30:3552.
Allen, R.L. et al. (2001) J. Immunol. 167:5543.
Chang, C.C. et al. (2002) Nat. Immunol. 3:237.
Ristich, V. et al. (2005) Eur. J. Immunol. 35:1133.
Manavalan, J.S. et al. (2003) Transpl. Immunol. 11:245.

Long Name

Leukocyte Immunoglobulin-like Receptor, Subfamily B (with TM and ITIM Domains), Member 5

Entrez Gene IDs

10288 (Human)

Alternate Names

CD85 antigen-like family member D; CD85d antigen; CD85d; Ig-like transcript 4; ILT4; ILT-4; ILT4CD85d; Immunoglobulin-like transcript 4; Leukocyte immunoglobulin-like receptor 2; leukocyte immunoglobulin-like receptor subfamily B member 2 soluble isoform; leukocyte immunoglobulin-like receptor subfamily B member 2; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains); LILRB2; LIR2; LIR2CD85D; LIR-2subfamily A (with TM domain), member 6; member 2; MIR10; MIR10LILRA6; Monocyte/macrophage immunoglobulin-like receptor 10